Scopolamine Market - Size, Share, Trends, and Forecast, 2022 - 2028

Scopolamine Market - Size, Share, Trends, and Forecast, 2022 - 2028

Scopolamine is an oral, intravenous, ophthalmic or topical drug derived from plants of the nightshade family (Solanaceae), specifically Hyoscyamus Niger and Atropa belladonna, with anticholinergic, antiemetic and antivertigo properties.
It has applications in prevention of nausea, vomiting, and dizziness associated with motion sickness and recovery from anesthesia and surgery. Scopolamine may also be used to treat certain stomach or intestinal problems, such as spastic muscle states, diverticulitis, irritable bowel syndrome, Parkinson-like conditions etc.
Market Dynamics
Changing lifestyle that involves minimal or absolutely no physical work in a routine life are responsible for the malfunctioning of the digestive as well as gastrointestinal system. Increasing number of population adopting long-hour sedentary work lifestyle are likely to be affected with gastrointestinal disorders such as irritable bowel syndrome and thus are responsible to support growth of the global scopolamine market.
However, various side-effects observed while using these drugs such as retarded motion, drowsiness, and diluted pupils, may limit their growth to some extent in the near future.
Key features of the study:

This report provides in-depth analysis of the scopolamine market, market size (US$ Mn) and cumulative annual growth rate (CAGR (%)) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global scopolamine market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Baxter International Inc., GlaxoSmithKline plc, Novartis AG, Perrigo Company plc, Caleb Pharmaceuticals, Inc., Myungmoon Pharma Co. LTD., Alchem International, Phytex Australia, Centroflora-Cms, Alkaloids of Australia, and Fine Chemicals Corporation.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global scopolamine market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for scopolamine market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

Global Scopolamine Market, By Dosage Form:

Tablet
Syrup
Injection
Patch
Others

Global Scopolamine Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Scopolamine Market, By Region:

North America

By Country:

U.S.
Canada

By Dosage Form:

Tablet
Syrup
Injection
Patch
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Europe

By Country:

U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe

By Dosage Form:

Tablet
Syrup
Injection
Patch
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Asia Pacific

By Country:

Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific

By Dosage Form:

Tablet
Syrup
Injection
Patch
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Latin America

By Country:

Brazil
Mexico
Argentina
Rest of Latin America

By Dosage Form:

Tablet
Syrup
Injection
Patch
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Middle East

By Country:

GCC
Israel
Rest of Middle East

By Dosage Form:

Tablet
Syrup
Injection
Patch
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Africa

By Country:

South Africa
Central Africa
North Africa

By Dosage Form:

Tablet
Syrup
Injection
Patch
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Company Profiles

Baxter International Inc.*

Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies

GlaxoSmithKline plc
Novartis AG
Perrigo Company plc.
Caleb Pharmaceuticals, Inc.
Myungmoon Pharma Co. LTD.
Alchem International
Phytex Australia
Centroflora-Cms
Alkaloids of Australia
Fine Chemicals Corporation

“*” marked represents similar segmentation in other categories in the respective section.